Novartis (NVS) is not new to these hallowed pages. Longtime readers (and we appreciate you not pointing out our long absence) will recall that Novartis spun off Alcon(ALC) in April 2019. Last week, however, Novartis completed one of the final steps in its upcoming Sandoz(SDZ) spinoff. At a (fairly ordinary) extraordinary shareholder meeting on September 15, 2023, Novartis… Read More »
Another month is almost in the books so lets recap the recent spinoff activity and also take a look at what spinoffs the next month will bring: Spinoffs Completed Prior Month Some big spinoffs in April. April 1st – after several years of merger integration work, DowDupont (DWDP) began breaking itself up last month with the spin off… Read More »
Last week, Novartis(NVS) completed its spinoff of Alcon(ALC). Less than a decade ago, Novartis had purchased Alcon from Nestle(NSRGY), but new leadership decided to reverse the transaction. In an article this weekend, Barron’s suggests that there is more than meets the eye to Alcon. Barron’s notes that, on the surface, Alcon looks expensive. For now, Wall Street is… Read More »
Novartis’ (NVS) eye care spinoff Alcon is ready to go. The distribution is set for April 9th and both shareholders and ADR holders as of April 8th will receive one share of Alcon stock for every 5 Novartis shares owned. Alcon will trade in both Switzerland and the NYSE under the ticker ‘ALC’ so a shareholder with 100… Read More »